Last 12 months
Inside the activity.
0 purchase rows · 83 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 17 |
| Apr 2026 | 0 | 8 |
| May 2026 | 0 | 9 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 9 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 12, 2026 Filed Oct 13, 2026 20:00 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-26-000099 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,745 Underlying: Common Stock · 7,500 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 12, 2026 Filed Oct 13, 2026 20:00 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 7,500 | $62.88 | $471,600.00 |
DisclosureSEC source: 0001061983-26-000099 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 278,544 Read SEC document |
| October 12, 2026 Filed Oct 13, 2026 20:00 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 7,500 | $10.60 | $79,500.00 |
DisclosureSEC source: 0001061983-26-000099 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 06, 2026 Filed Oct 6, 2026 20:25 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001061983-26-000098 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,886 Underlying: Common Stock · 3,500 shares Expires 2028-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 06, 2026 Filed Oct 6, 2026 20:25 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 3,500 | $61.38 | $214,830.00 |
DisclosureSEC source: 0001061983-26-000098 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,902 Read SEC document |
| October 06, 2026 Filed Oct 6, 2026 20:25 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 3,500 | $7.80 | $27,300.00 |
DisclosureSEC source: 0001061983-26-000098 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 28, 2026 Filed Sep 28, 2026 20:54 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-26-000097 · form4.xml · derivative · entry 6 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 149,245 Underlying: Common Stock · 7,500 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 28, 2026 Filed Sep 28, 2026 20:54 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 7,500 | $65.46 | $490,950.00 |
DisclosureSEC source: 0001061983-26-000097 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 278,544 Read SEC document |
| September 28, 2026 Filed Sep 28, 2026 20:54 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 7,500 | $10.60 | $79,500.00 |
DisclosureSEC source: 0001061983-26-000097 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2026 Filed Sep 22, 2026 22:14 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001061983-26-000096 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,386 Underlying: Common Stock · 3,500 shares Expires 2028-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2026 Filed Sep 22, 2026 22:14 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 3,500 | $68.29 | $239,015.00 |
DisclosureSEC source: 0001061983-26-000096 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,902 Read SEC document |
| September 22, 2026 Filed Sep 22, 2026 22:14 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 3,500 | $7.80 | $27,300.00 |
DisclosureSEC source: 0001061983-26-000096 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2026 Filed Sep 15, 2026 21:23 UTC |
Landry Robert EDirector
|
SaleCommon Stock | 1,000 | $72.13 | $72,130.00 |
DisclosureSEC source: 0001061983-26-000095 · form4.xml · nonDerivative · entry 1 Landry Robert E · CIK 0001585160 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,184 Read SEC document |
| September 15, 2026 Filed Sep 15, 2026 21:20 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 97,926 | $69.33 | $6,789,209.58 |
DisclosureSEC source: 0001061983-26-000094 · form4.xml · nonDerivative · entry 6 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Indirect · by Trust 3. Beneficial Ownership Disclaimed. Disclosed balance after: 0 F6 · kind: Sale of shares of common stock by The Bridget Blum 2026 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the shares sold or the proceeds thereof. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 21:20 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-26-000094 · form4.xml · derivative · entry 9 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 156,745 Underlying: Common Stock · 7,500 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · kind: Exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c). Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 21:20 UTC |
Blum Robert IDirector · President & CEO
|
GiftCommon Stock | 97,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-26-000094 · form4.xml · nonDerivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Indirect · by Trust 3. Beneficial Ownership Disclaimed. Disclosed balance after: 97,926 F5 · kind: Acquisition of shares by The Bridget Blum 2026 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the shares held by the aforementioned trust. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 21:20 UTC |
Blum Robert IDirector · President & CEO
|
GiftCommon Stock | 97,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-26-000094 · form4.xml · nonDerivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 278,544 F4 · kind: Transfer of shares of common stock to The Bridget Blum 2026 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the shares held by the aforementioned trust upon completion of the gift transfer. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 21:20 UTC |
Blum Robert IDirector · President & CEO
|
GiftCommon Stock | 1,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-26-000094 · form4.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 376,470 F3 · kind: Charitable gift. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 21:20 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 7,500 | $73.44 | $550,800.00 |
DisclosureSEC source: 0001061983-26-000094 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 377,820 F2 · kind: Sale of shares of common stock acquired upon exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c). Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 21:20 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 7,500 | $10.60 | $79,500.00 |
DisclosureSEC source: 0001061983-26-000094 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 385,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquisition of shares of common stock upon exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c). Read SEC document |
| September 11, 2026 Filed Sep 11, 2026 23:12 UTC |
Landry Robert EDirector
|
SaleCommon Stock | 1,000 | $74.66 | $74,660.00 |
DisclosureSEC source: 0001061983-26-000093 · form4.xml · nonDerivative · entry 1 Landry Robert E · CIK 0001585160 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,184 Read SEC document |
| September 08, 2026 Filed Sep 8, 2026 20:38 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001061983-26-000092 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,886 Underlying: Common Stock · 3,500 shares Expires 2028-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2026 Filed Sep 8, 2026 20:38 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 3,500 | $75.46 | $264,110.00 |
DisclosureSEC source: 0001061983-26-000092 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,902 Read SEC document |
| September 08, 2026 Filed Sep 8, 2026 20:38 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 3,500 | $7.80 | $27,300.00 |
DisclosureSEC source: 0001061983-26-000092 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2026 Filed Sep 1, 2026 20:51 UTC |
PARSHALL B LYNNEDirector
|
SaleCommon Stock | 5,000 | $71.48 | $357,400.00 |
DisclosureSEC source: 0001061983-26-000091 · form4.xml · nonDerivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,784 Read SEC document |
| August 31, 2026 Filed Aug 31, 2026 20:57 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $23.26 | $0.00 |
DisclosureSEC source: 0001061983-26-000090 · form4.xml · derivative · entry 3 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2031-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| August 31, 2026 Filed Aug 31, 2026 20:57 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 10,000 | $70.24 | $702,400.00 |
DisclosureSEC source: 0001061983-26-000090 · form4.xml · nonDerivative · entry 2 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,555 Read SEC document |
| August 31, 2026 Filed Aug 31, 2026 20:57 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 10,000 | $23.26 | $232,600.00 |
DisclosureSEC source: 0001061983-26-000090 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2026 Filed Aug 31, 2026 20:55 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-26-000089 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 164,245 Underlying: Common Stock · 7,500 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2026 Filed Aug 31, 2026 20:55 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 7,500 | $70.24 | $526,800.00 |
DisclosureSEC source: 0001061983-26-000089 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 377,820 Read SEC document |
| August 31, 2026 Filed Aug 31, 2026 20:55 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 7,500 | $10.60 | $79,500.00 |
DisclosureSEC source: 0001061983-26-000089 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 385,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2026 Filed Aug 18, 2026 20:38 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001061983-26-000088 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,386 Underlying: Common Stock · 3,500 shares Expires 2028-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2026 Filed Aug 18, 2026 20:38 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 3,500 | $75.82 | $265,370.00 |
DisclosureSEC source: 0001061983-26-000088 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,902 Read SEC document |
| August 18, 2026 Filed Aug 18, 2026 20:38 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 3,500 | $7.80 | $27,300.00 |
DisclosureSEC source: 0001061983-26-000088 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2026 Filed Aug 10, 2026 21:11 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-26-000087 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,745 Underlying: Common Stock · 7,500 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2026 Filed Aug 10, 2026 21:11 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 7,500 | $76.76 | $575,700.00 |
DisclosureSEC source: 0001061983-26-000087 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 377,820 Read SEC document |
| August 10, 2026 Filed Aug 10, 2026 21:11 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 7,500 | $10.60 | $79,500.00 |
DisclosureSEC source: 0001061983-26-000087 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 385,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2026 Filed Jul 30, 2026 20:26 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $23.26 | $0.00 |
DisclosureSEC source: 0001061983-26-000086 · form4.xml · derivative · entry 3 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 14,000 shares Expires 2031-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| July 30, 2026 Filed Jul 30, 2026 20:26 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
SaleCommon Stock | 14,000 | $79.88 | $1,118,320.00 |
DisclosureSEC source: 0001061983-26-000086 · form4.xml · nonDerivative · entry 2 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,555 Read SEC document |
| July 30, 2026 Filed Jul 30, 2026 20:26 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 14,000 | $23.26 | $325,640.00 |
DisclosureSEC source: 0001061983-26-000086 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2026 Filed Jul 27, 2026 20:33 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-26-000085 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 179,245 Underlying: Common Stock · 7,500 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2026 Filed Jul 27, 2026 20:33 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 7,500 | $80.87 | $606,525.00 |
DisclosureSEC source: 0001061983-26-000085 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 377,820 Read SEC document |
| July 27, 2026 Filed Jul 27, 2026 20:33 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 7,500 | $10.60 | $79,500.00 |
DisclosureSEC source: 0001061983-26-000085 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 385,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2026 Filed Jul 23, 2026 20:09 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001061983-26-000084 · form4.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,886 Underlying: Common Stock · 3,500 shares Expires 2028-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2026 Filed Jul 23, 2026 20:09 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 3,500 | $80.59 | $282,065.00 |
DisclosureSEC source: 0001061983-26-000084 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,902 Read SEC document |
| July 21, 2026 Filed Jul 23, 2026 20:09 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 3,500 | $7.80 | $27,300.00 |
DisclosureSEC source: 0001061983-26-000084 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:34 UTC |
WIERENGA WENDELLDirector
|
GrantCommon Stock | 75 | $82.62 | $6,196.50 |
DisclosureSEC source: 0001061983-26-000082 · form4.xml · nonDerivative · entry 1 WIERENGA WENDELL · CIK 0001239956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,563 F1 · kind: Shares of common stock granted pursuant to the Cytokinetics Equity in lieu of Cash Retainer Program. Shares are fully vested at the time of grant. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:35 UTC |
Wysenski NancyDirector
|
GrantCommon Stock | 75 | $82.62 | $6,196.50 |
DisclosureSEC source: 0001061983-26-000083 · form4.xml · nonDerivative · entry 1 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,992 F1 · kind: Shares of common stock granted pursuant to the Cytokinetics Equity in lieu of Cash Retainer Program. Shares are fully vested at the time of grant. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:32 UTC |
Kaye Edward M. MDDirector
|
GrantCommon Stock | 151 | $82.62 | $12,475.62 |
DisclosureSEC source: 0001061983-26-000081 · form4.xml · nonDerivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,434 F1 · kind: Shares of common stock granted pursuant to the Cytokinetics Equity in lieu of Cash Retainer Program. Shares are fully vested at the time of grant. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:31 UTC |
HENDERSON JOHN TDirector
|
GrantCommon Stock | 272 | $82.62 | $22,472.64 |
DisclosureSEC source: 0001061983-26-000080 · form4.xml · nonDerivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,360 F1 · kind: Shares of common stock granted pursuant to the Cytokinetics Equity in lieu of Cash Retainer Program. Shares are fully vested at the time of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.